Protection from high pressure induced hyperexcitability by the AMPA/Kainate receptor antagonists GYKI 52466 and LY 293558
- 31 May 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (5), 605-612
- https://doi.org/10.1016/0028-3908(94)90164-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- (3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonistJournal of Medicinal Chemistry, 1993
- Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone ratEpilepsy Research, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- The effects of the competitive NMDA receptor antagonist CPP on the high pressure neurological syndrome in a primate modelNeuropharmacology, 1991
- GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneuronesNeuroscience Letters, 1991
- The effects of MK801 on the high pressure neurological syndrome in the baboon (Papio anubis)Neuropharmacology, 1990
- Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466European Journal of Pharmacology, 1989
- 2-Amino-phosphonoheptanoic acid protects against the high pressure neurological syndromeEuropean Journal of Pharmacology, 1983
- An Extension of Shapiro and Wilk's W Test for Normality to Large SamplesJournal of the Royal Statistical Society Series C: Applied Statistics, 1982
- A Simple Test for a Set of Sums of SquaresJournal of the Royal Statistical Society Series C: Applied Statistics, 1981